HEAL.MED COMMUNITY INTEREST COMPANY

Company Registration Number:
12746664 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2023

Period of accounts

Start date: 1 April 2022

End date: 31 March 2023

HEAL.MED COMMUNITY INTEREST COMPANY

Contents of the Financial Statements

for the Period Ended 31 March 2023

Directors report
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

HEAL.MED COMMUNITY INTEREST COMPANY

Directors' report period ended 31 March 2023

The directors present their report with the financial statements of the company for the period ended 31 March 2023

Directors

The directors shown below have held office during the whole of the period from
1 April 2022 to 31 March 2023

Dr J E Greening
Ms S Lockwood-Lee
Mr L Paxman-Clarke


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
7 September 2023

And signed on behalf of the board by:
Name: Mr L Paxman-Clarke
Status: Director

HEAL.MED COMMUNITY INTEREST COMPANY

Balance sheet

As at 31 March 2023

Notes 2023 2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 1,906 1,963
Total fixed assets: 1,906 1,963
Current assets
Stocks: 4 4,000 1,500
Debtors: 5 20,073 6,336
Cash at bank and in hand: 15,119 36,770
Investments:   0 0
Total current assets: 39,192 44,606
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 6 ( 22,638 ) ( 18,119 )
Net current assets (liabilities): 16,554 26,487
Total assets less current liabilities: 18,460 28,450
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: ( 362 ) ( 373 )
Accruals and deferred income: 0 0
Total net assets (liabilities): 18,098 28,077
Capital and reserves
Called up share capital: 3 3
Share premium account: 0 0
Other reserves: 0 0
Profit and loss account: 18,095 28,074
Total Shareholders' funds: 18,098 28,077

The notes form part of these financial statements

HEAL.MED COMMUNITY INTEREST COMPANY

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 7 September 2023
and signed on behalf of the board by:

Name: Mr L Paxman-Clarke
Status: Director

The notes form part of these financial statements

HEAL.MED COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Grant income is recognised once the company has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.Revenue is recognised when the risks and rewards of ownership are transferred and this is defined to be on completion of services.

    Tangible fixed assets depreciation policy

    Depreciation is provided at 25% reducing balance method and at 33% on cost method for fixtures and fittings and computer equipment, respectively.

    Other accounting policies

    StocksStocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. DebtorsShort term debtors are measured at transaction price, less any impairment. Loans receivable are measuredinitially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.CreditorsShort term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

HEAL.MED COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 3 3

HEAL.MED COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 April 2022 541 2,352 2,893
Additions 185 816 1,001
Disposals
Revaluations
Transfers
At 31 March 2023 726 3,168 3,894
Depreciation
At 1 April 2022 146 784 930
Charge for year 118 940 1,058
On disposals
Other adjustments
At 31 March 2023 264 1,724 1,988
Net book value
At 31 March 2023 462 1,444 1,906
At 31 March 2022 395 1,568 1,963

HEAL.MED COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Stocks

2023 2022
£ £
Stocks 4,000 1,500
Total 4,000 1,500

HEAL.MED COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 March 2023

5. Debtors

2023 2022
£ £
Trade debtors 5,460 0
Other debtors 14,613 6,336
Total 20,073 6,336

HEAL.MED COMMUNITY INTEREST COMPANY

Notes to the Financial Statements

for the Period Ended 31 March 2023

6. Creditors: amounts falling due within one year note

2023 2022
£ £
Taxation and social security 1,064 5,209
Other creditors 21,574 12,910
Total 22,638 18,119

COMMUNITY INTEREST ANNUAL REPORT

HEAL.MED COMMUNITY INTEREST COMPANY

Company Number: 12746664 (England and Wales)

Year Ending: 31 March 2023

Company activities and impact

HEAL.med continues to support the type-1 diabetes community by creating valuable resources, delivering critical training to Healthcare Professionals (HCP’s) and engaging with key professionals networking events.In 2022/23 HEAL.med delivered projects in collaboration with the Leicester Hospitals Charity, the Leicester Royal Infirmary and many other partners.HEAL.med has invested significantly in developing and improving in education and app for the benefit of the community.The team worked with the children’s diabetes team to pilot a new method of delivering training to school teachers in the local area, with the results being disseminated at ATTD 2023 to the wider diabetes community.HEAL.med attended ISPAD 2022 to present a poster highlighting the valuable work the team has been doing.Our education programme Deapp was awarded with a QiC (Quality in Care) Award, a prestigious and industry recognised achievement, highlighting the impact that the brand has across the UK.The team has strengthened their links with major MedTech companies such as Dexcom and other UK charities, Pop 4 Diabetes, T1 Today and Diabetes UK.

Consultation with stakeholders

Stakeholders such as HCPs play a key role in development of education for the Deapp Educational programme. This includes sub-groups of specialists that collaborate with the team to ensure the content created is medically accurate and suitable for the community. Engagement and input continues throughout the development process and feedback is continually taken on board.Feedback from the community of users of Deapp education is carefully taken onboard and implemented to ensure continual development and improvement of the services that the team offers.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
7 September 2023

And signed on behalf of the board by:
Name: Mr L R Paxman-Clarke
Status: Director